Skip to content

Clinical trials

Carcinoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Country / region: Switzerland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20091
20111
20121
20161
20181
20204
20211
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting3
Unknown status2
Terminated2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Ariad Pharmaceuticals1
AstraZeneca1
Blueprint Medicines Corporation1
Boston Scientific Corporation1
Daiichi Sankyo1
Exelixis1
Hoffmann-La Roche1
Iovance Biotherapeutics, Inc.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma19
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms6
Neoplasms5
Adenocarcinoma4
Neoplasms by Site4
Carcinoma, Hepatocellular3
Head and Neck Neoplasms3
Lung Diseases3
Neoplasms by Histologic Type3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.